Samuel N Hazen Hca Healthcare, Inc. (HCA) insider trading activity

Samuel N Hazen is CEO of HCA Healthcare, Inc.. Currently has a direct ownership of 63,200 shares of HCA, which is worth approximately $25.7 Million. The most recent transaction as insider was on Aug 06, 2024, when has been sold 22,211 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 63.2K

76.22% 3M change

58.22% 12M change

Total Value Held $25.7 Million

SAMUEL N HAZEN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 06 2024	SELL Bona fide gift	-	22,211 Reduced 26.0%	63,200 Common Stock
Feb 16 2024	SELL Payment of exercise price or tax liability	$9,375,908 $308.55 p/Share	30,387 Reduced 10.26%	265,744 Common Stock
Feb 16 2024	BUY Grant, award, or other acquisition	-	78,440 Added 20.94%	296,131 Common Stock
May 04 2023	SELL Bona fide gift	-	12,511 Reduced 7.64%	151,276 Common Stock
Feb 17 2023	SELL Payment of exercise price or tax liability	$9,664,626 $262.84 p/Share	36,770 Reduced 18.33%	163,787 Common Stock
Feb 17 2023	BUY Grant, award, or other acquisition	-	94,880 Added 32.12%	200,557 Common Stock
Feb 03 2023	SELL Payment of exercise price or tax liability	$8,312,240 $258.08 p/Share	32,208 Reduced 23.36%	105,677 Common Stock
Feb 03 2023	BUY Exercise of conversion of derivative security	$4,068,639 $68.96 p/Share	59,000 Added 29.97%	137,885 Common Stock
Feb 18 2022	SELL Payment of exercise price or tax liability	$8,746,103 $244.1 p/Share	35,830 Reduced 8.64%	378,885 Common Stock
Feb 18 2022	BUY Exercise of conversion of derivative security	-	6,011 Added 1.43%	414,715 Common Stock
Feb 18 2022	BUY Grant, award, or other acquisition	-	85,040 Added 17.22%	408,704 Common Stock
Nov 02 2021	SELL Open market or private sale	$12,587,500 $251.75 p/Share	50,000 Reduced 13.38%	323,664 Common Stock
Oct 29 2021	SELL Payment of exercise price or tax liability	$19,483,284 $250.46 p/Share	77,790 Reduced 17.23%	373,664 Common Stock
Oct 29 2021	BUY Exercise of conversion of derivative security	$7,321,421 $47.97 p/Share	152,625 Added 25.27%	451,454 Common Stock
Feb 18 2021	SELL Payment of exercise price or tax liability	$3,192,220 $174.61 p/Share	18,282 Reduced 5.77%	298,829 Common Stock
Feb 18 2021	BUY Grant, award, or other acquisition	-	48,635 Added 13.3%	317,111 Common Stock
Nov 03 2020	SELL Payment of exercise price or tax liability	$30,965,918 $136.09 p/Share	227,540 Reduced 36.83%	390,351 Common Stock
Nov 03 2020	SELL Open market or private sale	$16,556,719 $135.85 p/Share	121,875 Reduced 31.22%	268,476 Common Stock
Nov 03 2020	BUY Exercise of conversion of derivative security	$13,471,283 $24.18 p/Share	557,125 Added 47.41%	617,891 Common Stock

SNH

Samuel N Hazen

CEO

Nashville, TN

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HCA shares.

Notify only if

Value

Insider Trading

Get notified when an Hca Healthcare, Inc. insider buys or sells HCA shares.

Notify only if

Operation

Value

Type

News

Receive news related to HCA Healthcare, Inc.

Track Activities on HCA

Account